Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Peele, P. B.
Right arrow Articles by Ravdin, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peele, P. B.
Right arrow Articles by Ravdin, P. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information

Pamela B. Peele, PhD

Department of Health Policy & Management, Graduate School of Public Health, University of Pittsburgh, peele{at}pitt.edu

Laura A. Siminoff, PhD

Department of Bioethics, School of Medicine, Case Western Reserve University, Cleveland OH

Ying Xu, MS

Department of Health Policy & Management, Graduate School of Public Health, University of Pittsburgh

Peter M. Ravdin, MD

Department of Medicine, University of Texas Health Science Center, San Antonio

Objective. Oncology patients often seek involvement in their medical consultations. Such involvement is endorsed by most health care providers and mirrored in practice guidelines. However, oncologists exhibit great variation in how they provide patients with disease-relevant information, and many remain reluctant to do so at all. The authors examined the impact of a patient-specific decision aid on women’s decisions about adjuvant therapy for breast cancer. Method. 386 women with breast cancer were randomized to receive either an informational pamphlet about adjuvant therapy (usual care) or a patient-specific, evidence-based decision aid about adjuvant therapy. The authors compared rates of adjuvant therapy between the groups controlling for age, education, marital status, race, tumor severity, and practice type of their physician (university-based or community-based). Results. Among women with low tumor severity, only 58% (35/60) of women in the decision aid group chose adjuvant therapy, compared to 87% (33/38) of their counterparts in usual care (P < 0.01). Conclusions. This study illustrates the important impact of medical decision aids on treatment choices, particularly for patients for whom treatment has little benefit. In the case of adjuvant therapy for breast cancer, providing individualized, evidence-based risk information for shared decision making resulted in fewer women with low tumor severity choosing adjuvant treatment.

Key Words: decision aid • cancer • decision making • information preferences

Medical Decision Making, Vol. 25, No. 3, 301-307 (2005)
DOI: 10.1177/0272989X05276851


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
A. J. Vickers, E. B. Elkin, P. B. Peele, M. Dickler, and L. A. Siminoff
Long-Term Health Outcomes of a Decision Aid: Data from a Randomized Trial of Adjuvant! in Women with Localized Breast Cancer
Med Decis Making, July 1, 2009; 29(4): 461 - 467.
[Abstract] [PDF]


Home page
Int J Qual Health CareHome page
M. Ouwens, M. Hulscher, R. Hermens, M. Faber, H. Marres, H. Wollersheim, and R. Grol
Implementation of integrated care for patients with cancer: a systematic review of interventions and effects
Int. J. Qual. Health Care, April 1, 2009; 21(2): 137 - 144.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. A. O'Brien, T. J. Whelan, M. Villasis-Keever, A. Gafni, C. Charles, R. Roberts, S. Schiff, and W. Cai
Are Cancer-Related Decision Aids Effective? A Systematic Review and Meta-Analysis
J. Clin. Oncol., February 20, 2009; 27(6): 974 - 985.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. M. Ozanne, D. Braithwaite, K. Sepucha, D. Moore, L. Esserman, and J. Belkora
Sensitivity to Input Variability of the Adjuvant! Online Breast Cancer Prognostic Model
J. Clin. Oncol., January 10, 2009; 27(2): 214 - 219.
[Abstract] [Full Text] [PDF]


Home page
Med Care Res RevHome page
S. Leatherman and L. Warrick
Effectiveness of Decision Aids: A Review of the Evidence
Med Care Res Rev, December 1, 2008; 65(6_suppl): 79S - 116S.
[Abstract] [PDF]


Home page
BMJHome page
D. F Munday and E J. Maher
Informed consent and palliative chemotherapy
BMJ, July 31, 2008; 337(jul31_3): a868 - a868.
[Full Text]


Home page
JAMAHome page
S. E. Harrington and T. J. Smith
The Role of Chemotherapy at the End of Life: "When Is Enough, Enough?"
JAMA, June 11, 2008; 299(22): 2667 - 2678.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. J. van Tol-Geerdink, P. F.M. Stalmeier, E. N.J.T. van Lin, E. C. Schimmel, H. Huizenga, W. A.J. van Daal, and J.-W. Leer
Do Patients With Localized Prostate Cancer Treatment Really Want More Aggressive Treatment?
J. Clin. Oncol., October 1, 2006; 24(28): 4581 - 4586.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Matsuyama, S. Reddy, and T. J. Smith
Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From Cancer
J. Clin. Oncol., July 20, 2006; 24(21): 3490 - 3496.
[Abstract] [Full Text] [PDF]